Fidelity Investments’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.45B | Buy |
40,357,821
+953,728
| +2% | +$34.4M | 0.08% | 201 |
|
|
2025
Q1 | $1.23B | Buy |
39,404,093
+13,024,760
| +49% | +$405M | 0.08% | 216 |
|
|
2024
Q4 | $673M | Sell |
26,379,333
-1,510,810
| -5% | -$38.5M | 0.04% | 365 |
|
|
2024
Q3 | $789M | Buy |
27,890,143
+3,442
| +0% | +$97.4K | 0.05% | 334 |
|
|
2024
Q2 | $735M | Sell |
27,886,701
-5,747,515
| -17% | -$152M | 0.05% | 328 |
|
|
2024
Q1 | $1.02B | Buy |
33,634,216
+2,050,287
| +6% | +$62.3M | 0.07% | 256 |
|
|
2023
Q4 | $887M | Buy |
31,583,929
+1,156,757
| +4% | +$32.5M | 0.07% | 257 |
|
|
2023
Q3 | $826M | Sell |
30,427,172
-3,457,078
| -10% | -$93.8M | 0.07% | 242 |
|
|
2023
Q2 | $1.04B | Sell |
33,884,250
-6,099,866
| -15% | -$188M | 0.09% | 204 |
|
|
2023
Q1 | $1.44B | Sell |
39,984,116
-4,126,249
| -9% | -$149M | 0.13% | 136 |
|
|
2022
Q4 | $1.74B | Buy |
44,110,365
+1,152,485
| +3% | +$45.5M | 0.17% | 106 |
|
|
2022
Q3 | $1.73B | Buy |
42,957,880
+7,004,526
| +19% | +$281M | 0.18% | 96 |
|
|
2022
Q2 | $1.51B | Buy |
35,953,354
+7,748,193
| +27% | +$326M | 0.15% | 126 |
|
|
2022
Q1 | $1.1B | Buy |
28,205,161
+6,125,366
| +28% | +$239M | 0.09% | 205 |
|
|
2021
Q4 | $880M | Buy |
22,079,795
+2,970,038
| +16% | +$118M | 0.07% | 282 |
|
|
2021
Q3 | $691M | Sell |
19,109,757
-4,986,172
| -21% | -$180M | 0.05% | 324 |
|
|
2021
Q2 | $988M | Sell |
24,095,929
-3,856,891
| -14% | -$158M | 0.08% | 233 |
|
|
2021
Q1 | $1.22B | Buy |
27,952,820
+3,010,272
| +12% | +$131M | 0.1% | 181 |
|
|
2020
Q4 | $1.25B | Buy |
24,942,548
+6,754,244
| +37% | +$338M | 0.11% | 168 |
|
|
2020
Q3 | $754M | Buy |
18,188,304
+1,831,813
| +11% | +$75.9M | 0.08% | 228 |
|
|
2020
Q2 | $743M | Buy |
+16,356,491
| New | +$743M | 0.08% | 217 |
|